Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Lifted Cadre Holdings (NYSE:CDRE) Order Backlog to USD 338.2 Million?

Backlog rose USD 148.4 million since year end. Orders for vehicle blast attenuation seats, blast exposure monitoring sensors and remotely operated vehicles added USD 93.4 million, the current-year acquisition USD 39.7 million and nuclear safety products USD 10.6 million. Duty gear holsters across channels …

Vinay Lochav | 05 November 2026

Why Did Magnite (NASDAQ:MGNI) Rocket 17.09% After a 20% Jump in Contribution ex-TAC?

Adjusted EBITDA was USD 83.4 million, up 46%, and the margin widened to 42% from 34%, showingOperating Leverageas extra revenue costs little to process. For the fourth quarter Magnite guided contribution ex-TAC of USD 227 million to USD 233 million. For 2026 it now …

Vinay Lochav | 05 November 2026

How Did CF Industries (NYSE:CF) Lift Q3 Adjusted EBITDA to USD 833 Million From USD 667 Million?

Last-twelve-month cash from operations was USD 3.1 billion and freeCash FlowUSD 2.0 billion, a 53% conversion of adjusted EBITDA, or 61% excluding USD 306 million of deposits to Canada tied to a United States and CanadaTransfer Pricingmatter. Management notes those deposits will be applied …

Vinay Lochav | 05 November 2026

Can Cognex (NASDAQ:CGNX) Hold a 32.2% Operating Margin After Raising Its 2026 Outlook?

GAAP net income was USD 85 million versus USD 18 million, while adjusted net income was USD 90 million versus USD 56 million. The year-ago quarter is distorted by the commercial partnership with a medical lab automation channel partner, so excluding it adjusted EPS …

Vinay Lochav | 05 November 2026

Why Is Chord Energy (NASDAQ:CHRD) Adjusted EPS USD 6.08 Against GAAP EPS of USD 3.29?

Net cash fromOperating Activitieswas USD 781.4 million, adjusted EBITDA (non-GAAP) was USD 871.3 million and adjusted freeCash Flowwas USD 431.5 million, or USD 442 million excluding reimbursableCapitalspending. The release text pairs USD 871.3 million with operating cash flow, but the tables show it as …

Vinay Lochav | 05 November 2026

Top 5 Stocks Moving on 5th: Q3 Earnings Winners, From Xeris and ADMA to Vericel, Arq and CareCloud

Key HighlightsXeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% after third quarterRevenueclimbed 44% to USD 107.2 million and the 2030 revenue outlook was lifted above USD 1 billion.Vericel Corporation (NASDAQ:VCEL) gained 20.27% after revenue grew 26% to USD 85.4 million and full-year guidance was raised …

Vinay Lochav | 05 November 2026

How Did Chime Financial (NASDAQ:CHYM) Reach a 32% Revenue Jump and 10.9 Million Members?

The financial technology company offers low-cost banking and payments products, with deposits insured through partner banks. MyPay origination volume hit a record USD 5.3 billion with loss rates around 1%, annualized revenue above USD 500 million and record transaction profit of USD 80 million. …

Vinay Lochav | 05 November 2026

Top 5 Stocks Moving on 5th: Q3 Reports That Sank Shares, From Veracyte and MNTN to BuzzFeed, 3D Systems and Fastly

Key HighlightsVeracyte, Inc. (NASDAQ:VCYT) fell 54.9% and MNTN fell 54% after results released on November 4, 2026, both tied to lower guidance rather than a collapse in the reported quarter.BuzzFeed, Inc. (NASDAQ:BZFD) fell 38% after third quarterRevenuedropped 44% to USD 26.0 million and management …

Vinay Lochav | 05 November 2026

Why Did Clene (NASDAQ:CLNN) Report a USD 3.9 Million Profit on USD 56 Thousand of Revenue?

Key HighlightsNet income was USD 3.9 million for the third quarter of 2026, versus a net loss of USD 8.8 million a year earlier, after a USD 6.3 million loss from operations.Fair value gains of USD 7.5 million onWarrantliabilities and USD 3.4 million on …

Vinay Lochav | 05 November 2026

Top 5 Stocks Moving on 5th: Healthcare Gainers, From a Preferred Stock Redemption to a USD 125 Million Raise

Key HighlightsLakewood-Amedex Biotherapeutics Inc. (NASDAQ:LABT) was quoted 290.33% higher after retiring all Series C preferred stock for USD 1,270,970, a nano-cap move on about 45 times normal volume.Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) rose 29.68% on 44%Revenuegrowth to USD 107.2 million, raised 2026 guidance and …

Vinay Lochav | 05 November 2026
Support

Hi! How can we help you today?

Loading…